A Study to Determine the Feasibility of Primary Care Referrals to Community-based Lifestyle Programs for Obesity Management

Overview

About this study

The purposes of this study are to:  evaluate the feasibility of providing a community based referral to Mayo Clinic ECH patients for weight loss by measuring the number of patients who follow through with the referral, to determine the completion rate of patients enrolled through provider referral to a community based weight loss program, and to determine the level of provider and patient satisfaction with the community based weight loss program process.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who are between 18-65 years of age
  • Patients who have a BMI between 25-39.9 kg/m2
  • Patients ability to complete the Diabetes Prevention Program including dietary and physical activity recommendations
  • Patients motivated to lose weight (assessed to be in the preparation or action stage)
  • Patients and providers ability to provide informed consent
  • Providers on the study team or ExercisAbilities staff

Exclusion Criteria

  • Have used weight loss medications or participated in a weight loss program within the past 30 days.
  • Are currently enrolled in DPP or other ExercisAbilities weight loss programs.
  • Are currently taking supplements known to affect weight.
  • Have had weight fluctuations of 20 pounds or more in the past 6 months (EMR check and self-report).
  • Have an active untreated clinically significant psychiatric condition (psychosis, bipolar disorder, or depression).
  • Are currently pregnant or breastfeeding, or are of child-bearing potential and are likely to become pregnant during the study (within the next 4 months following enrollment).
  • Have a history in the past 4 months of any major cardiovascular events including heart valve disease, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease.
  • Have current uncontrolled hypertension (systolic > 160 mm Hg or diastolic > 95 mm Hg) documented on 2 separate occasions.
  • Have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as diabetes) or active cancer or are within 1 year of cancer remission.
  • Have a known history of any condition or factor judged by the investigator/study team to preclude participation in the study or which might hinder adherence.
  • Have any co-morbidity that is deemed exclusionary at the discretion of the provider.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Tamim Rajjo, M.D., M.P.H.

Open for enrollment

Contact information:

Heather Ondler Hinson M.S.

(507) 293-7891

OndlerHinson.Heather@mayo.edu

More information

Publications

Publications are currently not available